Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.

@article{Raldow2015RiskGA,
  title={Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.},
  author={Ann Raldow and Danjie Zhang and Ming-Hui Chen and Michelle H. Braccioforte and Brian J. Moran and Anthony V. D'Amico},
  journal={JAMA oncology},
  year={2015},
  volume={1 3},
  pages={
          334-40
        }
}
IMPORTANCE Active surveillance (AS), per the National Comprehensive Cancer Network (NCCN) guidelines, is considered for patients with low-risk prostate cancer (PC) and a life expectancy of at least 10 years. However, given the grade migration following the 2005 International Society of Urologic Pathology consensus conference, AS may be appropriate for men presenting with favorable intermediate-risk PC. OBJECTIVE To estimate and compare the risk of PC-specific mortality (PCSM) and all-cause… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 28 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 39 REFERENCES

Long-term follow-up of a large active surveillance cohort of patients with prostate cancer.

Cancer statistics, 2014.